Transgene Biotek closes securities trading window for insiders ahead of earnings release Back
<p>Transgene Biotek Limited informed the BSE Limited that the trading window for dealing in securities of the company will be closed for all Directors, Key Managerial Personnel, Designated Employees, and Connected Persons from October 1, 2026, until 48 hours after the declaration of the company’s Limited reviewed Financial Results for the second quarter ending September 30, 2026.</p>